CIK 0001498382
- Non-accelerated filer
- Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 990360497
- Phone
- +1 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 4 Other acquisition Director acquired 192 shares (other)
- 4 Other acquisition CEO acquired 120 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO, Director bought 7,500 shares at $1.47 ($11,025)
- 4 Open-market buy President, CEO bought 3,000 shares at an average $0.80 ($2,396)
- 4 Open-market buy President, CEO bought 4,000 shares at $0.83 ($3,320)
- 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $0.60 ($6,000)
- 4 Open-market buy President, CEO bought 10,000 shares at $0.60 ($6,000)
- 4 Open-market buy Chief Scientific Officer bought 75,000 shares at $0.60 ($45,000)
- 4 Open-market buy Director bought 50,000 shares at $0.60 ($30,000)
- 4 Open-market buy Director bought 16,666 shares at $0.60 ($10,000)
- 4 Open-market buy Chief Financial Officer bought 50,000 shares at $0.60 ($30,000)
- 4 Open-market buy President, CEO bought 50,000 shares at $0.60 ($30,000)
- 3 Insider Initial Statement of Ownership
Page 13 of 16 · 308 filings